Training In CBT & Other Evidence-Based Psychological Therapies
Introduction
The majority of adults consume substances (e.g., alcohol, tobacco, cannabis). Substance use disorders are among the most common psychiatric disorders and people with anxiety and depression are at a heightened risk for these disorders. In addition to the potential impact of disordered use, even non-disordered substance use can impact mood, cognition, sleep and therapeutic learning (e.g. extinction learning in exposure-based therapies) in ways that may impede treatment progress. This workshop will provide practical guidance on the identification and management of substance use and substance use disorders in people with anxiety and depression. Understanding how substance use, across the continuum of severity, can influence treatment for anxiety and depression and how to manage substance-related goals can be an essential for practitioners working with these populations. The overarching goal of this workshop is to help providers to feel more comfortable and skilled in identifying substance use severity, generating hypotheses about its impact on the individual, and managing substance use modification in the context of depression and anxiety treatment.
The event will be equivalent to 2.3/4 hrs of CPD.
Content
The workshop will provide a brief overview of evidence-based treatments for substance use in people with depression and anxiety, followed by in-depth discussion of tools for identifying and managing substance use. This will include identifying levels of substance use and their potential impact on symptoms and depression/anxiety treatment, determining when a referral may be needed for medical evaluation and management, and implementing strategies for identifying goals (e.g., reduction vs. abstinence) and modifying substance use in support of these goals. Potential modifications to depression and anxiety treatment unique to those with co-occurring substance use disorders will also be discussed.
Learning Objectives
(1) To understand the impact of substance use (across the continuum of severity) on depression and anxiety symptoms and on depression and anxiety treatment
(2) To identify potential misuse of substance use and substance use disorders
(3) To conduct a cognitive behavioral case conceptualization of substance misuse and to utilize functional analysis to inform intervention strategies.
(4) To be able to utilize specific cognitive-behavioral intervention strategies for substance use disorders.
Training Modalities
Training modalities will include didactic content, Q&A, case presentation, and self-experiential components.
Key References
(1) Kiluk, B.D, Nich, C., Babuscio, T., Carroll, K.M. (2010). Quality versus quantity: acquisition of coping skills following computerized cognitive-behavioral therapy for substance use disorders. Addiction,105(12),2120-2127.
(2) McHugh, R. K., Hearon, B. A., & Otto, M. W. (2010). Cognitive-behavioral therapy for substance use disorders. Psychiatr Clin North Am, 33: 511-525.
(3) Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020 Jun 1;3(6):e208279. doi: 10.1001/jamanetworkopen.2020.8279. PMID: 32558914; PMCID: PMC7305524.
(4) Carroll KM, Kiluk BD. Cognitive behavioral interventions for alcohol and drug use disorders: Through the stage model and back again. Psychol Addict Behav. 2017 Dec;31(8):847-861. doi: 10.1037/adb0000311. Epub 2017 Aug 31. PMID: 28857574; PMCID: PMC5714654.
(5) McHugh RK, Weiss RD. Alcohol Use Disorder and Depressive Disorders. Alcohol Res. 2019 Jan 1;40(1):arcr.v40.1.01. doi: 10.35946/arcr.v40.1.01. PMID: 31649834; PMCID: PMC6799954.
About the presenter
Dr Kate McHugh is the Chief of Psychology and Director of the Stress, Anxiety and Substance Use Laboratory at McLean Hospital and an Associate Professor at Harvard Medical School. Dr. McHugh's work focuses on the nature and treatment of substance use and other psychiatric disorders. Her work is currently funded by grants from the National Institute on Drug Abuse and she has published more than 180 manuscripts and book chapters as well as an edited book published by Oxford University Press. Dr McHugh served as the Co-Chair of the American Psychological Association Taskforce on Clinical Responses to the Opioid Crisis. She is a recipient of a number of awards, including the Ann M. Cataldo Excellence in Mentoring Award. Dr. McHugh is a practicing clinical psychologist, specializing in cognitive-behavioral therapy for the treatment of anxiety, depressive, and substance use disorders.
Who should attend
This workshop would be applicable to providers from any discipline who provide behavioral therapies to adolescents and adults with depression and anxiety. Although the focus will be on adults, discussion of developmental modifications for adolescents will be discussed. Providers do not need to have a background in substance use or addiction.